Administration

Biden’s Approval Rating ‘Underwater’ as Re-election Loom: CAPS-Harris Poll

Only 42% of respondents "strongly" or "somewhat approve" of Biden's job as president.

42 Texas Counties Support for Formal ‘Invasion’ Declaration

Article IV, Section 7 of the Texas Constitution authorizes the governor to “call forth the militia to execute the laws of the state, to suppress insurrections, and to repel invasions.”

White House, DOJ Tried to Hide Classified Doc Case

The White House and the Department of Justice (DOJ) reportedly tried to conceal the classified document case until it was exposed by the media.

U.S. Treasury Buys Time for Biden and GOP on Debt Limit Deal

The U.S. government bumped up against its debt limit Thursday, prompting the Treasury Department to take “extraordinary” accounting steps to avoid default — as friction between President Joe Biden and House Republicans raised concern about whether the U.S. can sidestep an economic crisis.

2nd COVID-19 Booster Provides Worse Protection Than 1st

The protection provided by a second COVID-19 vaccine booster was worse than that bestowed by an initial booster, with the shielding trending negative after a period of time, according to a new study.

Musk Says Biden Admin May ‘Weaponize Federal Agencies Against Twitter’ If Trump Returns to Platform

"Will be interesting to see how the Biden administration reacts to this. They may try to weaponize Federal agencies against Twitter," Musk tweeted.

DOJ Allowed Biden Attorneys to Handle Classified Docs Without FBI Oversight

DOJ declined to participate in the search.

New Zealand’s Jacinda Ardern to Step Down as Prime Minister

"I no longer have enough in the tank," Ardern said.

Pfizer, Fauci Staffers Sign Off on Research Finding mRNA COVID Vaccines Produce Worse Antibodies

Less than a month after the CDC marked the two-year anniversary of the first administered COVID-19 vaccine by telling Americans to get a bivalent booster, two peer-reviewed German studies have found that mRNA vaccines — the vast majority of the U.S. market — induce worse antibodies compared to traditional adenovirus vaccines.

Latest news

- Advertisement -spot_img